Article Text

0152: Weekly Docetaxel and Irinotecan in Platinum-Refractory and Resistant Ovarian Cancer: a Phase II Study of the Austrian Ago

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.